March 14, 2013

The Food and Drug Administration has approved a drug for obsessive compulsive disorder made by Par Pharmaceutical Cos., the drug maker said Thursday.

February 25, 2013

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a drug to treat opioid dependence.

February 19, 2013

Drug maker Gilead Sciences has recalled a single lot of an injected drug used to treat an opportunistic infection in AIDS patients due to the presence of foreign matter, the company said.

January 24, 2013

Canadian pharmacy retailer Rexall has unveiled its new flagship private brand, Be.better, a line of more than 100 products available exclusively at the more than 300 corporate Rexall and Rexall Pharma Plus stores.

December 21, 2012

A federal court decision means that a nontamper-resistant formulation of a painkiller made by Endo Health Solutions can enter the market early next month, the drug maker said.

December 6, 2012

Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

September 11, 2012

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

September 7, 2012

A Takeda drug designed to treat hypertension was statistically superior to another drug combination in reducing systolic blood pressure among patients in a 10-week, late-stage clinical trial.

August 23, 2012

A drug maker that specializes in pain medications started the third late-stage trial of a drug for treating pain in patients who have undergone certain surgeries.

August 8, 2012

The Food and Drug Administration has approved an oral painkiller made by Perrigo, the drug maker said Wednesday.

December 22, 2011

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

November 4, 2011

South of France Natural Body Care is launching a social media campaign anchored by its new blog,, which went live Friday.

October 27, 2011

Mylan has received final approval from the Food and Drug Administration for a drug designed to treat moderate to severe pain.

August 12, 2011

Lannett announced that it has started shipping morphine sulfate oral solution, a painkiller approved by the Food and Drug Administration in June.

August 2, 2011

The Food and Drug Administration has approved an opioid painkiller made by Covidien's generic drug division, the medical supply company said.

July 13, 2010

Unapproved use of a drug used to treat malaria can cause serious side effects, prompting...

February 28, 2009

Despite all the debate over the use of cough-cold medicines in children under the age of 12, sales of cough-cold medicines didn’t do too badly last year. For the 52 weeks ended Jan. 25, sales of all cough-cold remedies — including cough drops, cough syrups, cold-allergy liquids and cold-allergy tablets — were up 10.5%, totaling $4 billion across food, drug and mass outlets (minus Walmart) according to Information Resources Inc data. Of course, the lion’s share of that growth comes courtesy of the latest allergy reliever to make its way from prescription vials to over-the-counter aisles. Factoring out the sales impact of McNeil Consumer Healthcare’s Zyrtec, which generated in excess of $331 million across its Zyrtec syrup, Zyrtec tablet and Zyrtec-D tablet, the overall cough-cold category still grew by 1.4%. Considering that’s on a base of $3.6 billion, that represents incremental growth of almost $50 million.